Ultiva Injection, Powder, Lyophilized, For Solution
Product Images NDC 72078-036

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ultiva (NDC 72078-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ultiva (remifentanil Hydrochloride) Structural Formula (Image 01)

Chemical structure diagram of Remifentanil Hydrochloride, the active ingredient in Ultiva injection. The diagram depicts molecular bonds and functional groups representing its chemical composition.*

FDA Label Image

Figure 1: Recovery Of Respiratory Drive After Equipotent* Doses Of Ultiva And Alfentanil Using Co2-stimulated Minute Ventilation In Adult Volunteers (±1.5 Sem) (Image 02)

A line graph comparing minute ventilation (% of baseline) over time (minutes) between Ultiva and Alfentanil. The graph shows data during infusion and post-infusion phases, with Ultiva displaying an increase in minute ventilation after infusion compared to Alfentanil.*

FDA Label Image

Figure 2: Mean Concentration (sd) Versus Time (Image 03)

A line graph comparing mean serum concentrations (ng/mL) over time (minutes) for two drugs: Alfentanil at 0.5 mcg/kg/min and Ultiva (remifentanil hydrochloride) at 0.05 mcg/kg/min. The graph includes error bars indicating variability, showing differing concentration profiles for the two drugs across an 8-hour period.*

FDA Label Image

Ultiva Cii (remifentanil HCl) 1 mg Label (Image 04)

Packaging label for Ultiva injection, powder, lyophilized, for solution, containing 1 mg of remifentanil hydrochloride per vial. The label indicates it is for intravenous use only and includes 10 single-dose vials per package. Manufactured by Mylan Institutional LLC, the label features usage instructions and storage conditions (2° to 25°C).*

FDA Label Image

Ultiva Cii (remifentanil HCl) 2 mg Label (Image 05)

Packaging label for Ultiva 2 mg (remifentanil HCl) injection powder, lyophilized, for solution. The label indicates it is for intravenous use only and supplied as 10 single-dose vials of 2 mg each. The product is labeled by Mylan Institutional LLC, with usage and storage instructions included.*

FDA Label Image

Ultiva Cii (remifentanil HCl) 5 mg Label (Image 06)

Packaging label for Ultiva 5 mg (equivalent to 5 mg remifentanil) injection, lyophilized powder for solution. The product is for intravenous use only and supplied in 10 single-dose vials. Manufactured and distributed by Mylan Institutional LLC, the label includes storage instructions and dosage preparation directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.